Top of this page
Skip navigation, go straight to the content
This section is intended for media and financial analysts
08 Oct 2021
![New BIMZELX[®]▼ (bimekizumab) two-year data in moderate to severe plaque psoriasis presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress](/_up/ucb_com_presscenter/images/presscenter_teaser_20.jpg?300)
29 Sep 2021
24 Sep 2021
10 Sep 2021
![BIMZELX[®]▼ (bimekizumab) Receives First Positive Health Technology Assessment Worldwide](/_up/ucb_com_presscenter/images/presscenter_teaser_1.jpg?300)
06 Sep 2021
03 Sep 2021
Newsroom
•
Press Releases
Search Press releases
08 Oct 2021
Disposals of own shares
Read more29 Sep 2021
New BIMZELX[®]▼ (bimekizumab) two-year data in moderate to severe …
Read more24 Sep 2021
Disposals of own shares
Read more10 Sep 2021
Disposals of own shares
Read more06 Sep 2021
BIMZELX[®]▼ (bimekizumab) Receives First Positive Health Technology Assessment Worldwide …
Read more03 Sep 2021
Disposals of own shares
Read more
Stay up-to-date on the latest news and information from UCB